NCT00995904 - Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Asthma

Interventions

DRUG

84ug MAP0020

84ug of unit dose budesonide inhalation suspension delivered by Aeroneb® Go (MAP0020) as per protocol

DRUG

42ug MAP0020

42ug of unit dose budesonide inhalation suspension delivered by Aeroneb® Go (MAP0020) as per protocol

DRUG

21ug MAP0020

21ug of unit dose budesonide inhalation suspension delivered by Aeroneb® Go (MAP0020) as per protocol

Trial Locations (2)

West Coast Clinical Trials LLC, Cypress

Sylvana Research Associates, San Antonio